1Unteh B, Ahmad S, Jeske WP, et al. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of ISG. Thromb Res, 2002, 105 : 117-123.
2Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention : the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126 : 311S-337S.
3DeEugenio DL, Ruggiero N J, Thomson LJ, et al. Early-onset heparin- induced thrombocytopenia after a 165-day heparin-free interval:case report and review of the literature. Pharmacotherapy, 2005,25 : 615- 619.
4Woedyard DN. An anesthesia provider' s perspective of heparin-- induced v thrombocytopenia. AANA J,2005,73:115-119.
